[Prospective analysis of adverse reactions with long-term levofloxacin use].
The safety of the long-term use of levofloxacin as an antibiotic has not previously been reported via a prospective study. This lack of evidence acts as a barrier for its use as an anti-tuberculosis drug. Cases with long-term levofloxacin use were prospectively followed at member hospitals of Ryoken. The frequency of adverse events is reported. Of 91 total cases, 7 cases were reported to have adverse drug reactions that may or may not have been levofloxacin-related. Of these 7 cases, 5 reported arthralgia and muscle pain that occurred 37-157 days after starting levofloxacin. Of 49 bacillary-positive cases, 1 case died 1 month later, 1 case did not have a culture examination, and 47 cases showed culture conversion. Long-term levofloxacin use is likely to be safe; however, arthralgia should be monitored in these long-term users.